$RFL 3 SEC Filings

Filed On	Filing
31 Oct 2025	Form 3: Grayson Alan, Director Holds 0 shares of Class B Common Stock, par value $.01 per share
11 Aug 2025	Form 3: Fine Joshua M, Chief Operations Officer Holds 9,380 shares of Class B Common Stock, $.01 par value per share
22 Jul 2025	Form 3: Fine N Scott, Director Holds 335,348 shares of Class B Common Stock, par value $.01 per share
02 Apr 2025	Form 3: Sieger Markus, Director Holds 155,182 shares of Class B Common Stock, par value $.01 per share
13 Aug 2024	Form 3: Stein Mark N, Director Holds 0 shares of Class B Common Stock, $.01 par value per share
12 Jan 2024	Form 3: Goldberg John, CHIEF MEDICAL OFFICER Holds 0 shares of Class B Common Stock, $.01 par value per share
12 Jan 2024	Form 3: Bernstein Susan Y, Director Holds 1,600 shares of Class B Common Stock, $.01 par value per share
08 May 2023	Form 3: Rafael Holdings, Inc., 10% owner · Cyclo Therapeutics, Inc. Holds 2,514,970 shares of Common Stock, par value $0.0001 per share
30 Jan 2023	Form 3: Polinsky David, Chief Financial Officer Holds 130,780 shares of Class B Common Stock, par value $.01 per share
18 Jul 2022	Form 3: i9 PLUS, Llc, 10% owner Holds 3,338,367 shares of Class B Common Stock, par value $.01 per share
18 Oct 2021	Form 3: Huizinga Mary Margaret, Chief Devel. & Medical Officer Holds 0 shares of Class B Common Stock, par value $.01 per share
28 Sep 2021	Form 3: Marin Ashok D, Chief Legal Officer Holds 0 shares of Class B Common Stock, par value $.01 per share
17 Sep 2021	Form 3: Fabbio Patrick, Chief Financial Officer Holds 0 shares of Class B Common Stock, par value $.01 per share
22 Jun 2021	Form 3: McCamish Mark Anthony, Director Holds 0 shares of Class B Common Stock, par value $.01 per share
22 Jun 2021	Form 3: Klinger Shannon Thyme, Director Holds 0 shares of Class B Common Stock, par value $.01 per share
10 May 2021	Form 3: Mallik Ameet, CHIEF EXECUTIVE OFFICER Holds 0 shares of Class B Common Stock, par value $.01 per share
18 Mar 2021	Form 3: Conkling William, Chief Commercial Officer Holds 0 shares of Class B Common Stock, par value $.01 per share
14 Jan 2021	Form 3: Jonas Rachel, Director Holds 778 shares of Class B Common Stock, par value $.01 per share
14 Mar 2018	Form 3: Greenberg Stephen M, Director Holds 0 shares of Class B Common Stock, par value $.01 per share
14 Mar 2018	Form 3: Weiss Michael J, Director Holds 0 shares of Class B Common Stock, par value $.01 per share

Comments